MarketCap
Facebook
X
Telegram
Inhibrx Balance Sheet 2023-2011 | INBX
Brief overview of Inhibrx's assets and capital
The balance sheet is assessed across five available annual reports spanning 2019 to 2023.
Assets advanced +1,062.3% to $307.9 million from $26.5 million; annual growth near 84.6% reflects a fast increase in scale.
Liabilities grew more slowly than assets: +336.6% versus +1,062.3%. Expansion relied more on equity, improving funding quality.
Internal capital represents 14.1% of the balance sheet versus -353.2% five periods ago. The cushion is thin.
The balance sheet holds more cash than interest-bearing debt; net debt is -$274.8 million, indicating minimal leverage.
Cash accounts for 90.3% of assets versus 43.6% initially. The change indicates the degree of financial flexibility.
Retained earnings are negative at -$613.7 million. This reduces the formal capital cushion, although large shareholder returns may have contributed.
Balance sheet takeaway
Inhibrx's financial position is more positive than negative: the funding mix is workable, although the cushion is not unlimited.
Annual Balance Sheet Inhibrx
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-275 M | -269 M | -125 M | -120 M | -3.74 M | 7.39 M | 1.19 M | - | - | - | - | - | - |
Long Term Debt |
1.11 M | 3.17 M | 5.03 M | 6.71 M | 6.7 M | 3.56 M | 9.49 M | - | - | - | - | - | - |
Long Term Debt Current |
2.06 M | 1.86 M | 1.67 M | 1.5 M | 1.1 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 36.9 M | 99.5 M | 51.4 M | 30.7 M | - | - | - | - | - | - |
Total Current Liabilities |
56.3 M | 27.6 M | 22.5 M | 31.4 M | 20.6 M | - | - | - | - | - | - | - | - |
Total Liabilities |
264 M | 233 M | 98.1 M | 68.3 M | 60.6 M | 67.6 M | 39.7 M | - | - | - | - | - | - |
Deferred Revenue |
- | 166 K | 2.03 M | 3.08 M | 7.94 M | - | - | - | - | - | - | - | - |
Retained Earnings |
-614 M | -372 M | -227 M | -145 M | -69.3 M | -17.9 M | -28.8 M | - | - | - | - | - | - |
Total Assets |
308 M | 291 M | 150 M | 144 M | 26.5 M | 9.98 M | 17.2 M | - | - | - | - | - | - |
Cash and Cash Equivalents |
278 M | 274 M | 131 M | 129 M | 11.5 M | - | - | - | - | - | - | - | - |
Book Value |
43.5 M | 58.1 M | 52.4 M | 75.5 M | -34.1 M | -57.6 M | -22.4 M | - | - | - | - | - | - |
Total Shareholders Equity |
43.5 M | 58.1 M | 52.4 M | 75.5 M | -93.6 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Inhibrx
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
205 M | 1.65 M | 2.17 M | 2.68 M | 3.17 M | 3.66 M | 4.13 M | 4.59 M | 5.03 M | 5.47 M | 5.9 M | 6.31 M | 6.71 M | 7.1 M | 6.71 M | 6.71 M | 6.7 M | 6.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
277 M | 243 M | 238 M | 239 M | 233 M | 200 M | 198 M | 134 M | 98.1 M | 101 M | 97.6 M | 63.9 M | 68.3 M | 51.8 M | 68.3 M | 68.3 M | 60.6 M | 60.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | 119 K | 149 K | 166 K | 440 K | 717 K | 1.23 M | 2.03 M | 2.77 M | 3.24 M | 4.08 M | 3.08 M | 5.18 M | 3.08 M | 3.08 M | 7.94 M | 7.94 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-692 M | -520 M | -468 M | -421 M | -372 M | -331 M | -296 M | -258 M | -227 M | -206 M | -185 M | -165 M | -145 M | -128 M | -145 M | -145 M | -69.3 M | -69.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
289 M | 373 M | 213 M | 254 M | 291 M | 165 M | 193 M | 161 M | 150 M | 129 M | 142 M | 125 M | 144 M | 144 M | 144 M | 144 M | 26.5 M | 26.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
252 M | 337 M | 192 M | 234 M | 274 M | 146 M | 176 M | 143 M | 131 M | 113 M | 126 M | 108 M | 129 M | 128 M | 129 M | 129 M | 11.5 M | 11.5 M | - | - | 2.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
11.6 M | 130 M | -24.8 M | 15.1 M | 58.1 M | -35 M | -4.92 M | 27.4 M | 52.4 M | 28.2 M | 44.3 M | 60.6 M | 75.5 M | 91.7 M | 75.5 M | 75.5 M | -34.1 M | -34.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
11.6 M | 130 M | -24.8 M | 15.1 M | 58.1 M | -35 M | -4.92 M | 27.4 M | 52.4 M | 28.2 M | 44.3 M | 60.6 M | 75.5 M | 91.7 M | 75.5 M | 75.5 M | -93.6 M | -93.6 M | -59.2 M | -60.6 M | -57.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Inhibrx, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
USA
Canada
China
France
Germany
Israel
Britain
Russia
Belgium
Cayman-islands